Insider Transactions in Q1 2023 at X4 Pharmaceuticals, Inc (XFOR)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2023
|
Adam S. Mostafa Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
52,500
-35.91%
|
$0
$0.84 P/Share
|
|
Mar 10
2023
|
Mary Di Biase Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
18,192
-10.64%
|
$0
$0.84 P/Share
|
|
Mar 10
2023
|
Paula Ragan President and CEO |
SELL
Open market or private sale
|
Direct |
49,678
-8.1%
|
$0
$0.84 P/Share
|
|
Mar 10
2023
|
Arthur Taveras Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
16,806
-16.29%
|
$0
$0.84 P/Share
|
|
Feb 13
2023
|
Paula Ragan President and CEO |
SELL
Open market or private sale
|
Direct |
21,695
-3.42%
|
$0
$0.93 P/Share
|
|
Feb 13
2023
|
Adam S. Mostafa Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
27,721
-15.94%
|
$0
$0.93 P/Share
|
|
Feb 13
2023
|
Mary Di Biase Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,348
-2.48%
|
$0
$0.93 P/Share
|
|
Feb 13
2023
|
Arthur Taveras Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
928
-0.89%
|
$0
$0.93 P/Share
|